CalciMedica Inc Live Stock Price Today, Share Analysis and Chart

Name: CalciMedica Inc: Is Infosys Ltd. worth buying?
Item: CalciMedica Inc
Rating: 0.64550
Author: Trendlyne DVM scores

about

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release...

0.68 -0.01 (-1.45%)

90.56% Fall from 52W High

80,721

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The latest board meeting for CalciMedica Inc took place on 14 May 2026, for the purpose of CalciMedica Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

25.8 / 100

No estimates available

CalciMedica Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CalciMedica Inc Live Stock Price Today, Share Analysis and Chart

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release...

90.56% Fall from 52W High

SWOT Analysis

CalciMedica Inc Live Price Chart